Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Robert Gottlieb et al.|The Lancet Respiratory Medicine|2022Cited by 127
The transcriptome of CD14+CD163-HLA-DRlow monocytes predicts mortality in Idiopathic Pulmonary FibrosisΤheodoros Karampitsakos, Jose D. Herazo‐Maya, Minxue Jia et al.|Unknown|2025Cited by 2